NasdaqCM - Delayed Quote USD
Lipocine Inc. (LPCN)
2.8700
-0.0500
(-1.71%)
At close: May 13 at 4:00:00 PM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| BASS GREGORY BROOKS Officer | Sale | Dec 29, 2017 | 5,625 |
| BROWN MORGAN R Chief Financial Officer | Sale | Dec 16, 2020 | 194,504 |
| FINK JEFFREY ARVIN Director | Conversion of Exercise of derivative security | Dec 16, 2020 | 6,562 |
| FOGARTY KRISTA Officer | Stock Award(Grant) | Mar 8, 2024 | 1,727 |
| HIGUCHI JOHN W Director | Sale | Dec 31, 2020 | 693,548 |
| HILL STEPHEN A Director | Conversion of Exercise of derivative security | Dec 16, 2020 | 12,750 |
| ONO RICHARD DANA Director | Purchase | Mar 20, 2023 | 14,125 |
| PAPAPETROPOULOS SPYROS M.D., PH.D. Director | Purchase | Nov 22, 2022 | 21,739 |
| PATEL MAHESH V Chief Executive Officer | Stock Award(Grant) | Mar 8, 2024 | 112,311 |
Related Tickers
GRCE Grace Therapeutics, Inc.
2.6000
-4.41%
CNTB Connect Biopharma Holdings Limited
0.7610
-5.17%
MIST Milestone Pharmaceuticals Inc.
1.1900
-0.83%
IOBT IO Biotech, Inc.
1.0000
-2.91%
ATRA Atara Biotherapeutics, Inc.
6.68
+3.25%
XFOR X4 Pharmaceuticals, Inc.
3.3100
-0.90%
IRD Opus Genetics, Inc.
0.9592
+0.97%
VNDA Vanda Pharmaceuticals Inc.
3.9800
-1.24%
CGTX Cognition Therapeutics, Inc.
0.3212
-1.74%
VTGN Vistagen Therapeutics, Inc.
2.3700
+2.16%